🇺🇸 FDA
Patent

US 10173989

1,2,4-oxadiazole derivatives as immunomodulators

granted A61KA61K31/395A61K31/4245

Quick answer

US patent 10173989 (1,2,4-oxadiazole derivatives as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/395, A61K31/4245, A61K31/433, A61K45/06